Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
don't worry, you will know soon enough on Monday.
Ok, and what is your conclusion?
Why would people start selling if I am providing a prediction that the FDA would provide a decision by this monday???
Ok. I am providing a prediction. That was what I stated initially. Lets see what happens.
agreed. We shall see. We only have to wait until this Monday.
Actually there are two in that article.
March 20 and April 17th, both Mondays. Thats considered more than one and a pattern.
From the article:
"North Carolina-based Humacyte claimed the first RMAT designation on March 20, 2017, for its investigational human acellular vessel (HAV). On Monday, the less than one-year-old rare disease company Enzyvant claimed the second and a BTD to boot."
And regarding the CEO blog, its says and i quote "the FDA is afforded additional regulatory processing time."
Its ok...I will wait for your response.
No, I disagree. They are going to push this down hard to shake as many shares as they can. Everyone needs to understand that there isn't that many shares to trade. Yes, we are at 325M shares...but I can bet you that several of those shares are restricted and you can't trade them for a certain period of time.
If this news comes out on Monday and its positive, the MMs are going to have a really hard time finding shares to cover orders.
Wording is everything. It does not say that the FDA is provided additional 60 days. It does say that the 60 day "Clock" is reset, (Or does not expire around March 27th). Then it goes to say that the FDA is provided addiotnal time. Additional is the KEY word.
Its Math.
Again, I don't see within the CEO Blog that he states that the FDA is provided an additional 60 Days.
I believe people are misreading that Blog. The CEO does not say that the FDA is given an additional 60 days but "the FDA is afforded ADDITIONAL regulatory processing time."
Well if early April is the re-start date, then I still believe Monday, May 1st would be the announcement. As I had mentioned earlier, 30 or 45 day extensions are usually the norm for Government. Your statement would allow it to fall under the 30 day extension which is usual extension time frame.
Doubling down...
The Rizz
Monday, May 1st RMAT decision will be provided.
As you can see on the link, FDA provides RMAT decisions on Mondays.
http://medcitynews.com/2017/04/enzyvant-regenerative-medicine-advanced-therapy-rmat-designation/
I made a prediction that either yesterday or Monday, May 1st, a decision would be made. Zero yesterday.
My calculations are based on the Blog posts provided by the CEO and commentary here.
Jan 27th Filing. Some time before the 60 day deadline they received a request for more information and additional time was added. Knowing how the Government works, its usually a 30 or 45 day extension. I have never heard of a full reset on time that equals the initial time frame. Since 30 days passed and we have a good idea which day FDA announces RMAT, it appears Monday, May 1st is D-DAY.
You heard it hear.
The Rizz
No, not until actual stock purchase occurs.
Everyone needs to stay calm. This isn't a selloff but MMs pushing to trigger sell stop triggers. They got their shares that they need.
Prediction is still for RMAT either this Monday or the next Monday. Expect more games likes this so the MMs can have enough shares to cover the action once the announcement.
You have to remember, everyone knows that news is coming out so they have time to prepare. Usually it isn't structured this way.
The Rizz
Sorry, I meant next monday or May 1st. Thoughts?
I meant to say either next monday or May 1st.
Sorry.
The Rizz
Prediction:
FDA decision will be coming out either next Monday or Feb 1st which is the following monday. You heard it here first.
The Rizz
I have to agree!
but I also need to see what the big money is going to do. This investment by a PE is a big signal to the rest of the world regarding USRM. If we don't see this stock start moving upwards then something is really wrong with their application.
i hope your right. My only concern is that the last two trading days we have seen so much shorting that the MMs may try to weigh this down so they can exit.
Which would be a big win for GACP if that is the case.
I read somewhere on this board that US Stem Cell has around 7 Million in outstanding debt. I am sure the execs will need time to structure the best scenario on paying off a majority of it OR they will need the monies after RMAT designation to finalize the requirements. Either way, they need time hence UP TO is the keywords.
Agreed. Think about it.
They locked in a price for 63 Million shares as they feel that the chances for RMAT approval are high. However, Smart Money is typically SMART and wants to make sure that they don't expose themselves to high RISK.
Remember, Stem Cells are a game changer which means BIG Pharma will be hit the most.
I am loading here as I am leaning towards what General American is doing.
$2.5M for clinics
$5 M for Corporate
Thats a lot for a Penny company.
Shady:
It went up after the 3 blind article because everyone thinks that was a hit piece by big Pharma to keep USRM down and hurt RMAT application.
Think about it. USRM is a major threat to Big Pharma since it would be truly a first. You need to follow the money.
Wow, so $2.5 Million for Clinics and $5 Million for US Stem Cell Inc. I think this GACP is really really interested in USRM. Not good for the Shorts.
Isn't this the same company that is opening the clinics?
I would look up Joseph Dagrosa. Plenty of reading material. Very impressive. This could definitely be the right investor for USRM!
so imagine the buying pressure on Monday when the rest of the world who is on vacation today and tomorrow comes in on work on Monday to find out that GACP just put in $5 Million into US Stem. Wow, Wow, Wow.
remember that day when it was around 3:30 and it exploded upwards. It feels like that right about now.
We are lining up for a Johnson & Johnson purchase. You heard it first from the Rizzler.
But that same firm would have to hold shares for a longer period of time...3 to 6 months at minimum.
Reminder: Expected slow day of trading today. Monday we will see the real movement. They are covering now.
Rizz Rocket blast off.
$5 Million to pay off majority of US Stem's debt. Not good for Shorts.
Majority of Debt to be paid off!
GACP to invest 5 million dollars takes out a majority of the debt. Wow, the shorts entire argument was all the debt that it had. To Jupiter!
rizzler strikes again!
One more day folks.
Easily breaches .15 on Thursday.
Easily breaches .15 Thursday.
yeah but why is bar chart showing that tomorrow is the next earnings date?